CS
BLUE

Credit Suisse’s bluebird bio BLUE Stock Holding History

Credit Suisse’s Portfolio BLUE Stock Details BLUE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-3,690
Closed -$2.07M – 4298
2020
Q4 		$2.07M Hold
3,690
– – ﹤0.01% 2793
2020
Q3 		$2.58M Buy
3,690
+2,393
+185% +$1.87M ﹤0.01% 2238
2020
Q2 		$1.02M Buy
+1,297
New +$978K ﹤0.01% 2889
2020
Q1 		– Sell
-3,065
Closed -$3.48M – 3995
2019
Q4 		$3.48M Buy
+3,065
New +$3.33M ﹤0.01% 2160
2019
Q1 		– Sell
-988
Closed -$1.27M – 3985
2018
Q4 		$1.27M Buy
+988
New +$1.52M ﹤0.01% 2594

Other funds holding BLUE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Credit Suisse's BLUE Position: Q1 2024 in Review

Credit Suisse sold out of bluebird bio (BLUE) in Q1 2024, closing a stake of 3,532 shares — an estimated $97.5K sold.

Credit Suisse first reported a position in BLUE in Q1 2014 and held it in 40 quarters. The position peaked at $84.3M in Q2 2021. 158 funds tracked by Wall St. Rank hold BLUE as of Q1 2024.

  • Credit Suisse reported no remaining bluebird bio position as of Q1 2024 after selling out during the quarter.
  • Credit Suisse sold 3,532 bluebird bio shares in Q1 2024, an estimated $97.5K.
  • Credit Suisse first reported a position in bluebird bio in Q1 2014 and held it in 40 quarters.
  • Credit Suisse's bluebird bio position peaked at $84.3M in Q2 2021.
  • 158 funds tracked by Wall St. Rank held bluebird bio as of Q1 2024.

Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.